Mapping large numbers of results may take a few moments.
Search Results
Showing 1 - 40 of 40 results found.
Company | Activity | Company Description | Location | |
---|---|---|---|---|
Company 3i-Nano | Activity: Research and Development | Company Description 3i Nano develops point-of-care devices for disease diagnostics and protein detection. Potential applications include cardiac, sepsis, meningitis, and respiratory. | Location Greensboro | |
Company Acclivity Technologies Inc. | Activity: Research and Development | Company Description Acclivity is a virtual pharma company developing novel small molecule therapeutics for treatment of peripheral artery disease and other cardiovascular, inflammatory and ischemic disease indications, vasculitis and type 2 diabetes. | Location Raleigh | |
Company Accord Healthcare Inc. | Activity: Sales and Operations | Company Description Accord Healthcare is the marketing subsidiary of Intas Pharmaceuticals, an India-based company that focuses on manufacturing generic pharmaceuticals and biosimilars for the global market. | Location Durham | |
Company Aerami Therapeutics | Activity: Research and Development | Company Description Aerami is developing therapies to address the unmet medical needs of people with serious and rare forms of pulmonary hypertension, including pulmonary hypertension associated with interstitial lung disease and pulmonary arterial hypertension. | Location Durham | |
Company Affinergy LLC | Activity: Research and Development | Company Description Affinergy develops diagnostic tools for rare and difficult to diagnose diseases. Affinergy's development programs include rapid assays for proteins, drugs, cells and small molecules. | Location Durham | |
Company Amgen Inc. | Activity: Production and Manufacturing | Company Description Amgen will manufacture therapeutics for cardiovascular disease, oncology, bone health, neuroscience, nephrology and inflammation. The site is expected to be operational by 2025. | Location Apex | |
Company APIE Therapeutics Inc. | Activity: Research and Development | Company Description APIE Therapeutics is developing therapies for fibrosis and related diseases. Its biology platform is the activation of the Apelinergic System signaling pathway via Apelin/APJ receptors agonist drug therapies. | Location Research Triangle Park | |
Company AskBio | Activity: Research and Development | Company Description Asklepios BioPharmaceutical (AskBio) uses adeno-associated virus (AAV) technology to develop and manufacture gene therapies for rare diseases and other genetic disorders. | Location Research Triangle Park | |
Company Baebies Inc. | Activity: Production and Manufacturing | Company Description Baebies is a medical device company that develops and commercializes products to enable early disease detection and comprehensive diagnosis for children and adults. | Location Durham | |
Company Basking Biosciences Inc. | Activity: Research and Development | Company Description Basking Biosciences is developing a reversible anti-thrombotic therapeutic to treat ischemic stroke. | Location Research Triangle Park | |
Company Bio 54 LLC | Activity: Research and Development | Company Description Bio 54 is developing a hand-held drug delivery device for patients to treat external bleeding from minor wounds in anticoagulant patients. | Location Chapel Hill | |
Company Caidya | Activity: Contract Research and Testing | Company Description Caidya provides full global CRO service to pharmaceutical and biotechnology companies, working across all major therapeutic areas including oncology, gastroenterology and women's health and rare disease. | Location Morrisville | |
Company CardioPharma Inc. | Activity: Research and Development | Company Description CardioPharma develops combinatorial products to treat cardiovascular disease. | Location Wilmington | |
Company Charles River Laboratories (Durham) | Activity: Contract Research and Testing | Company Description Charles River Laboratories' Oncology Center of Excellence provides in vivo and in vitro oncology and immuno-oncology research services. | Location Durham | |
Company Chiesi USA Inc. | Activity: Research and Development | Company Description Chiesi USA, the U.S. affiliate of Chiesi Farmaceutici S.p.A, develops and commercializes products in the therapeutic areas of rare disease, respiratory, cardiovascular, neonatology and cystic fibrosis. | Location Cary | |
Company CMP Pharma Inc. | Activity: Production and Manufacturing | Company Description CMP develops, manufactures and commercializes niche oral liquid medications that address the needs of patients with difficulty swallowing solid dosage forms. | Location Farmville | |
Company Contego Medical LLC | Activity: Research and Development | Company Description Contego Medical develops embolic protection devices for cardiovascular and peripheral vascular procedures, designed to simplify catheter-based procedures. | Location Raleigh | |
Company DelAQUA Pharmaceuticals Inc. | Activity: Research and Development | Company Description DelAQUA Pharmaceuticals is developing technology to enhance the solubility and stability of drugs and drug candidates and to improve their efficacy and safety. | Location Chapel Hill | |
Company Grifols (RTP) | Activity: Sales and Operations | Company Description Grifols manufactures and markets plasma-derived medicines and other biopharmaceutical solutions to treat chronic, rare, and, at times, life-threatening conditions in the therapeutic areas of immunology, pulmonology, hematology, thrombolytics and neurology. | Location Research Triangle Park | |
Company Humacyte Inc. | Activity: Research and Development | Company Description Humacyte develops a technology platform that isolates and grows stable investigational human tissue replacements with potential regenerative medicine, vascular and nonvascular surgery applications. | Location Durham | |
Company Kowa Research Institute Inc. | Activity: Research and Development | Company Description Kowa Research Institute, a division of Kowa Company Ltd., develops therapeutic drugs for the treatment of cardio-metabolic diseases such as diabetes and atherosclerosis, pain and sensory organ disorders. | Location Morrisville | |
Company Liquidia Corporation | Activity: Research and Development | Company Description Liquidia Corporation develops and commercializes human therapeutics for the treatment of pulmonary arterial hypertension (PAH) and other applications using its proprietary particle engineering technology. | Location Morrisville | |
Company MD Scientific LLC | Activity: Research and Development | Company Description MD Scientific developed the EndoTool Glucose Management System and is currently developing a drug to prevent kidney and heart injury from iodinated contrast agents. | Location Charlotte | |
Company Milestone Pharmaceuticals USA Inc. | Activity: Research and Development | Company Description Milestone Pharmaceuticals is developing an investigational new drug intended to provide rapid-onset and short-acting treatment of paroxysmal supraventricular tachycardia (PSVT) episodes and other episodic conditions. | Location Charlotte | |
Company Momentum Research Inc. | Activity: Contract Research and Testing | Company Description Momentum Research manages and directs phase one through four clinical research projects and specializes in cardiovascular clinical trials management. | Location Durham | |
Company Nocturnal Product Development LLC | Activity: Contract Research and Testing | Company Description Nocturnal Product Development provides contract design and development services for Class II and Class III medical devices. The company is also developing an ablation catheter that enables real-time visualization of ablated cardiac tissue. | Location Durham | |
Company NuPulseCV | Activity: Research and Development | Company Description NuPulseCV is developing an implantable cardiovascular left ventricular assist device to treat people suffering from congestive heart failure. | Location Raleigh | |
Company PETNET Solutions Inc. (Winston-Salem) | Activity: Production and Manufacturing | Company Description PETNET manufactures positron emission tomography (PET) radiopharmaceuticals. | Location Winston-Salem | |
Company PETNET Solutions Inc., A Siemens Healthineers Company (Durham) | Activity: Production and Manufacturing | Company Description PETNET manufactures positron emission tomography (PET) radiopharmaceuticals. | Location Durham | |
Company QuatroBio LLC | Activity: Research and Development | Company Description QuatroBio provides oversight and strategic direction to several closely held drug development companies. | Location Morrisville | |
Company RT Cardiac Systems Inc. | Activity: Research and Development | Company Description RT Cardiac Systems is developing a proprietary blood pump technology for acute circulatory support to improve and advance therapy for high-risk percutaneous coronary intervention (HR PCI) and emergent heart failure. | Location Raleigh | |
Company Shear Induced Technologies | Activity: Research and Development | Company Description ShearIT is developing and commercializing Lamiflo, a non-pharmacologic treatment for cerebrovascular disease. | Location Lewisville | |
Company SonoVascular Inc. | Activity: Research and Development | Company Description SonoVascular has developed a novel pharmaco-mechanical ultrasound facilitated thrombectomy system that utilizes microbubble-mediated cavitation as a core enabling mechanism of action to more effectively treat deep vein thrombosis and pulmonary embolism. | Location Chapel Hill | |
Company Tenax Therapeutics Inc. | Activity: Research and Development | Company Description Tenax Therapeutics develops and commercializes pharmaceutical products for the critical care market. | Location Morrisville | |
Company United Therapeutics Corp. (RTP HQ) | Activity: Research and Development | Company Description United Therapeutics develops and commercializes products to treat cardiopulmonary diseases, infectious diseases and cancer. | Location Research Triangle Park | |
Company Vascular BioSciences Inc. | Activity: Research and Development | Company Description Vascular BioSciences is a biopharmaceutical company developing solutions for difficult-to-treat cardiovascular and inflammatory diseases. | Location Durham | |
Company Velo Bio LLC | Activity: Research and Development | Company Description Velo Bio is developing an orphan drug for the treatment of severe preeclampsia in pregnant women. | Location Morrisville | |
Company VitalEphX | Activity: Research and Development | Company Description VitalEphX develops therapeutics that preserve tissue viability and performance following myocardial infarction. | Location Greenville | |
Company Worldwide Clinical Trials Inc. | Activity: Contract Research and Testing | Company Description Worldwide Clinical Trials provides phase one through phase four drug development services to the pharmaceutical and biotechnology industries. | Location Research Triangle Park | |
Company Xollent Biotech Inc. | Activity: Research and Development | Company Description Xollent Biotech is developing a therapeutic to treat cardiovascular disease based on exosome-secreting cells. | Location Cary |